Antoniak S, Cardenas JC, Buczek LJ et al (2017) Protease-activated receptor 1 contributes to angiotensin II-induced cardiovascular remodeling and inflammation. Cardiology 136(4):258–268. https://doi.org/10.1159/000452269
CAS Article PubMed Google Scholar
Asokananthan N, Graham PT, Fink J et al (2002) Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 168(7):3577–3585. https://doi.org/10.4049/jimmunol.168.7.3577
CAS Article PubMed Google Scholar
Austin KM, Covic L, Kuliopulos A (2013) Matrix metalloproteases and PAR1 activation. Blood, J Hematol Am Soc 121(3):431–439
Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab 38(3):183–191. https://doi.org/10.1016/j.diabet.2011.11.006
CAS Article PubMed Google Scholar
Chen H, Smith M, Herz J et al (2021) The role of protease-activated receptor 1 signaling in CD8 T cell effector functions. Iscience 24(11):103387. https://doi.org/10.1016/j.isci.2021.103387
CAS Article PubMed PubMed Central Google Scholar
Cunningham MA, Rondeau E, Chen X et al (2000) Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191(3):455–462. https://doi.org/10.1084/jem.191.3.455
CAS Article PubMed PubMed Central Google Scholar
De Beer FC, Hind CR, Fox KM et al (1982) Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Heart 47(3):239–243. https://doi.org/10.1136/hrt.47.3.239
de Jager J, Dekker JM, Kooy A et al (2006) Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn study. Arterioscler Thromb Vasc Biol 26(5):1086–1093. https://doi.org/10.1161/01.ATV.0000215951.36219.a4
CAS Article PubMed Google Scholar
DeFronzo RA, Ferrannini E, Groop L et al (2015) Type 2 diabetes mellitus. Nat Rev Dis Primers 1(1):1–22. https://doi.org/10.1038/nrdp.2015.19
Dobrica E, Gaman MA, Cozma MA, Gaman AM, Diaconu CC (2019) Macrovascular and microvascular complications in type 2 diabetes mellitus: did hypertension change the setting? J Hypertens 37:e140–e141. https://doi.org/10.1097/01.hjh.0000571816.00025.b3
El Sheikh WM, Alahmar IE, Salem GM, El-Sheikh MA (2019) Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus. Egypt J Neurol Psychiatry Neurosurg 55(1):1–7. https://doi.org/10.1186/s41983-019-0080-0
El-Edel RH, Fathy WM, Abou-Elela DH, Emara MM, El-Khair NT (2020) Role of tumor necrosis factor alpha in type 2 diabetic nephropathy. Menoufia Med J 33(3):920. https://doi.org/10.4103/mmj.mmj_430_18
Fan Y, Zhang W, Mulholland M (2005) Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells1. J Surg Res 129(2):196–201. https://doi.org/10.1016/j.jss.2005.07.041
CAS Article PubMed Google Scholar
Fang X, Liao R, Yu Y, Li J, Guo Z, Zhu T (2019) Thrombin induces secretion of multiple cytokines and expression of protease-activated receptors in mouse mast cell line. Mediat Inflamm. https://doi.org/10.1155/2019/4952131
Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26(2):77–82. https://doi.org/10.2337/diaclin.26.2.77
Galicia-Garcia U, Benito-Vicente A, Jebari S et al (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275. https://doi.org/10.3390/ijms21176275
CAS Article PubMed Central Google Scholar
Ganz ML, Wintfeld N, Li Q et al (2014) The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetol Metab Syndr 6(1):1–8. https://doi.org/10.1186/1758-5996-6-50
Ghouse J, Isaksen JL, Skov MW et al (2020) Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes. Diabetes Obes Metab 22(2):231–242. https://doi.org/10.1111/dom.13891
CAS Article PubMed Google Scholar
Gray N, Picone G, Sloan F, Yashkin A (2015) The relationship between BMI and onset of diabetes mellitus and its complications. South Med J 108(1):29. https://doi.org/10.14423/SMJ.0000000000000214
Article PubMed PubMed Central Google Scholar
Guh DP, Zhang W, Bansback N et al (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9(1):1–20. https://doi.org/10.1186/1471-2458-9-88
Gupta R, Pamecha H (2020) To study relationship of serum hsCRP with type 2 diabetes mellitus, its vascular complications and non-diabetics-case control study. J Assoc Phys India 68(8):25–29
Heuberger DM, Schuepbach RA (2019) Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thrombosis J 17:4. https://doi.org/10.1186/s12959-019-0194-8
Hurley A, Smith M, Karpova T et al (2013) Enhanced effector function of CD8+ T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1. J Infect Dis 207(4):638–650. https://doi.org/10.1093/infdis/jis730
CAS Article PubMed Google Scholar
Junge CE, Sugawara T, Mannaioni G et al (2003) The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci 100(22):13019–13024. https://doi.org/10.1073/pnas.2235594100
CAS Article PubMed PubMed Central Google Scholar
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Investig 103(6):879–887. https://doi.org/10.1172/JCI6042
CAS Article PubMed PubMed Central Google Scholar
Kanmani S, Kwon M, Shin MK, Kim MK (2019) Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep 9(1):1–8. https://doi.org/10.1038/s41598-019-40987-8
Lee PR, Johnson TP, Gnanapavan S et al (2017) Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β. J Neuroinflammation 14(1):1–8. https://doi.org/10.1186/s12974-017-0901-y
Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH (2014) T cells in vascular inflammatory diseases. Front Immunol 5:504. https://doi.org/10.3389/fimmu.2014.00504
CAS Article PubMed PubMed Central Google Scholar
Liu X, Yu J, Song S, Yue X, Li Q (2017) Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer. Oncotarget 8(63):107334
Liu Y, Tang ZZ, Zhang YM et al (2020) Thrombin/PAR-1 activation induces endothelial damages via NLRP1 inflammasome in gestational diabetes. Biochem Pharmacol 175:113849. https://doi.org/10.1016/j.bcp.2020.113849
CAS Article PubMed Google Scholar
Mari B, Imbert V, Belhacene N et al (1994) Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem 269(11):8517–8523. https://doi.org/10.1016/S0021-9258(17)37225-3
CAS Article PubMed Google Scholar
Navale AM, Paranjape AN (2013) Role of inflammation in development of diabetic complications and commonly used inflammatory markers with respect to diabetic complications. Int J Pharm Pharm Sci 5(Suppl 2):1–5
Nazari A, Sardoo AM, Fard ET et al (2017) Is IL-6 increased in type 2 diabetes mellitus patients independent of nephropathic complication. Endocrinol Diabetes Obes 5(2):1102
Pan A, Wang Y, Yuan JM, Koh WP (2017) High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case–control study nested within the Singapore Chinese Health Study. BMC Endocr Disord 17(1):1–8. https://doi.org/10.1186/s12902-017-0159-5
Pawlinski R, Tencati M, Hampton CR et al (2007) Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation 116(20):2298–2306. https://doi.org/10.1161/CIRCULATIONAHA.107.692764
CAS Article PubMed PubMed Central Google Scholar
Pradeepa R, Mohan V (2021) Epidemiology of type 2 diabetes in India. Indian J Ophthalmol 69(11):2932. https://doi.org/10.4103/ijo.IJO_1627_21
Article PubMed PubMed Central Google Scholar
Randeria SN, Thomson GJ, Nell TA, Roberts T, Pretorius E (2019) Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol 18(1):1–5. https://doi.org/10.1186/s12933-019-0870-9
Reddy S, Amutha A, Rajalakshmi R et al (2017) Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy. J Diabetes Complicat 31(5):804–809. https://doi.org/10.1016/j.jdiacomp.2017.02.017
Roudbary SA, Saadat F, Forghanparast K, Sohrabnejad R (2011) Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Med Iran 49:149–152
Saeed MA, Ng GZ, Däbritz J et al (2017) Protease-activated receptor 1 plays a proinflammatory role in colitis by promoting Th17-related immunity. Inflamm Bowel Dis 23(4):593–602. https://doi.org/10.1097/MIB.0000000000001045
Sassy-Prigent C, Heudes D, Mandet C et al (2000) Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49(3):466–475. https://doi.org/10.2337/diabetes.49.3.466
CAS Article PubMed Google Scholar
Satoh J, Yagihashi S, Toyota T (2003) The possible role of tumor necrosis factor-α in diabetic polyneuropathy. Exp Diabesity Res 4(2)
留言 (0)